CASI Pharmaceuticals Inc (NASDAQ: CASI) stock closed at $5.50 on 6/28/24 after a major increase of 12.2%. Moreover, this advance was accompanied by exceptionally high trading volume at 297% of normal. The stock has risen 57.1% during the last week but has been extremely weak relative to the market over the last nine months.
Current PriceTarget Research Rating
CASI is expected to be a major Value Builder reflecting capital returns that are forecasted to be above the cost of capital.
CASI Pharmaceuticals has a current Value Trend Rating of F (Lowest Rating). This rating combines consistent signals from two proprietary PTR measures of a stock’s attractiveness. CASI Pharmaceuticals has a poor Power Rating of 16 and a very low Appreciation Score of 5, with the Lowest Value Trend Rating the result.
Rating Review
In light of this very positive price change we are reviewing our current Overall Rating of F. This review will be completed in the next several days.
Be the first to comment